+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
5239-82-7,MFCD00041544
Catalog No.:AA0038LV

5239-82-7 | Cyclopropylacetic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
95%
in stock  
$7.00   $5.00
- +
5g
97%
in stock  
$22.00   $15.00
- +
10g
97%
in stock  
$35.00   $24.00
- +
25g
97%
in stock  
$85.00   $59.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0038LV
Chemical Name:
Cyclopropylacetic acid
CAS Number:
5239-82-7
Molecular Formula:
C5H8O2
Molecular Weight:
100.1158
MDL Number:
MFCD00041544
SMILES:
OC(=O)CC1CC1
Properties
Computed Properties
 
Complexity:
84.1  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
7  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
0.8  

Downstream Synthesis Route

[1]Patent:WO2017/31325,2017,A1.Locationinpatent:Paragraph0688

[2]OrganicandBiomolecularChemistry,2013,vol.11,p.5994-5997

[3]Molecules,2014,vol.19,p.1527-1543

[4]JournalofOrganicChemistry,1994,vol.59,p.4791-4799

[5]ChemischeBerichte,1926,vol.59,p.1086

[6]SyntheticCommunications,1992,vol.22,p.773-782

[1]Patent:WO2005/49033,2005,A1.Locationinpatent:Page/Pagecolumn101

[2]Patent:WO2015/32790,2015,A1.Locationinpatent:Page/Pagecolumn32

[3]Patent:WO2015/110435,2015,A1.Locationinpatent:Page/Pagecolumn55

[4]OrganicandBiomolecularChemistry,2013,vol.11,p.5994-5997

[5]Molecules,2014,vol.19,p.1527-1543

[6]Patent:US2006/25477,2006,A1.Locationinpatent:Page/Pagecolumn8

[7]JournalofMedicinalChemistry,1984,vol.27,p.1291-1294

[8]JournalofOrganicChemistry,1994,vol.59,p.4791-4799

[9]Patent:US2006/94750,2006,A1.Locationinpatent:Page/Pagecolumn30

[10]Patent:WO2006/134341,2006,A1.Locationinpatent:Page/Pagecolumn68-69

[11]Patent:WO2007/9236,2007,A1.Locationinpatent:Page/Pagecolumn60

[12]Patent:US2008/188533,2008,A1.Locationinpatent:Page/Pagecolumn42

[13]Patent:US2008/214601,2008,A1.Locationinpatent:Page/Pagecolumn9

[14]JournaloftheAmericanChemicalSociety,2008,vol.130,p.13231-13233

[15]Patent:US2010/144745,2010,A1.Locationinpatent:Page/Pagecolumn48

[16]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.5074-5079

[17]Patent:US2011/130445,2011,A1.Locationinpatent:Page/Pagecolumn66

[18]JournaloftheAmericanChemicalSociety,2013,vol.135,p.7339-7348

[19]Patent:US2013/245042,2013,A1.Locationinpatent:Paragraph0102

[20]Patent:WO2013/192306,2013,A1.Locationinpatent:Page/Pagecolumn21

[21]MedChemComm,2014,vol.5,p.57-63

[22]Patent:WO2014/110705,2014,A1.Locationinpatent:Page/Pagecolumn131

[23]Patent:WO2014/151863,2014,A1.Locationinpatent:Page/Pagecolumn48

[24]Synthesis,2015,vol.47,p.1091-1100

[25]OrganicLetters,2015,vol.17,p.5898-5901

[26]ChemicalandPharmaceuticalBulletin,2016,vol.64,p.602-608

[27]Patent:WO2017/31325,2017,A1.Locationinpatent:Paragraph0668;0679

[28]Patent:WO2017/102091,2017,A1.Locationinpatent:Page/Pagecolumn346

[29]JournaloftheAmericanChemicalSociety,2017,vol.139,p.12153-12156

[30]EuropeanJournalofMedicinalChemistry,2018,vol.157,p.962-977

[31]OrganicLetters,2020,vol.22,p.234-238

[32]Patent:WO2019/213386,2019,A1.Locationinpatent:Paragraph0175

[33]Patent:WO2020/88659,2020,A1.Locationinpatent:Paragraph00232

[1]Patent:WO2015/112806,2015,A3.Locationinpatent:Paragraph0308

[2]Patent:US2010/16373,2010,A1.Locationinpatent:Page/Pagecolumn7

[3]Patent:US2020/190045,2020,A1.Locationinpatent:Paragraph0666;0667

[4]Patent:WO2017/97732,2017,A1.Locationinpatent:Page/Pagecolumn51;52

[5]Synlett,2019,vol.30,p.454-458

[6]Patent:WO2017/21969,2017,A1.Locationinpatent:Page/Pagecolumn29-30

[7]JournalofOrganicChemistry,2003,vol.68,p.9964-9970

[8]Patent:WO2014/97038,2014,A1.Locationinpatent:Page/Pagecolumn77

[9]Patent:WO2016/90285,2016,A1.Locationinpatent:Paragraph00361

[10]Patent:WO2020/115555,2020,A2.Locationinpatent:Page/Pagecolumn178-179

[1]Patent:US2003/187040,2003,A1

[2]JournalofOrganicChemistry,1994,vol.59,p.4791-4799

[1]Smith;McKenzie[JournalofOrganicChemistry,1950,vol.15,p.74,77]

Literature

Title: Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3.

Journal: The Journal of biological chemistry 20110325

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 5239-82-7
10191-25-0

10191-25-0

 10237-77-1

10237-77-1

 123-76-2

123-76-2

 13885-13-7

13885-13-7

 150-96-9

150-96-9

 150864-95-2

150864-95-2
Building Blocks
More >
Tags:5239-82-7 Molecular Formula|5239-82-7 MDL|5239-82-7 SMILES|5239-82-7 Cyclopropylacetic acid
Catalog No.: AA0038LV
5239-82-7,MFCD00041544
5239-82-7 | Cyclopropylacetic acid
Pack Size： 1g
Purity： 95%
in stock
$7.00 $5.00
Pack Size： 5g
Purity： 97%
in stock
$22.00 $15.00
Pack Size： 10g
Purity： 97%
in stock
$35.00 $24.00
Pack Size： 25g
Purity： 97%
in stock
$85.00 $59.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0038LV
Chemical Name: Cyclopropylacetic acid
CAS Number: 5239-82-7
Molecular Formula: C5H8O2
Molecular Weight: 100.1158
MDL Number: MFCD00041544
SMILES: OC(=O)CC1CC1
Properties
Complexity: 84.1  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 7  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 0.8  
Downstream Synthesis Route
6542-60-5    5239-82-7 

[1]Patent:WO2017/31325,2017,A1.Locationinpatent:Paragraph0688

[2]OrganicandBiomolecularChemistry,2013,vol.11,p.5994-5997

[3]Molecules,2014,vol.19,p.1527-1543

[4]JournalofOrganicChemistry,1994,vol.59,p.4791-4799

[5]ChemischeBerichte,1926,vol.59,p.1086

[6]SyntheticCommunications,1992,vol.22,p.773-782

5239-82-7    54322-65-5 

[1]Patent:WO2005/49033,2005,A1.Locationinpatent:Page/Pagecolumn101

[2]Patent:WO2015/32790,2015,A1.Locationinpatent:Page/Pagecolumn32

[3]Patent:WO2015/110435,2015,A1.Locationinpatent:Page/Pagecolumn55

[4]OrganicandBiomolecularChemistry,2013,vol.11,p.5994-5997

[5]Molecules,2014,vol.19,p.1527-1543

[6]Patent:US2006/25477,2006,A1.Locationinpatent:Page/Pagecolumn8

[7]JournalofMedicinalChemistry,1984,vol.27,p.1291-1294

[8]JournalofOrganicChemistry,1994,vol.59,p.4791-4799

[9]Patent:US2006/94750,2006,A1.Locationinpatent:Page/Pagecolumn30

[10]Patent:WO2006/134341,2006,A1.Locationinpatent:Page/Pagecolumn68-69

[11]Patent:WO2007/9236,2007,A1.Locationinpatent:Page/Pagecolumn60

[12]Patent:US2008/188533,2008,A1.Locationinpatent:Page/Pagecolumn42

[13]Patent:US2008/214601,2008,A1.Locationinpatent:Page/Pagecolumn9

[14]JournaloftheAmericanChemicalSociety,2008,vol.130,p.13231-13233

[15]Patent:US2010/144745,2010,A1.Locationinpatent:Page/Pagecolumn48

[16]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.5074-5079

[17]Patent:US2011/130445,2011,A1.Locationinpatent:Page/Pagecolumn66

[18]JournaloftheAmericanChemicalSociety,2013,vol.135,p.7339-7348

[19]Patent:US2013/245042,2013,A1.Locationinpatent:Paragraph0102

[20]Patent:WO2013/192306,2013,A1.Locationinpatent:Page/Pagecolumn21

[21]MedChemComm,2014,vol.5,p.57-63

[22]Patent:WO2014/110705,2014,A1.Locationinpatent:Page/Pagecolumn131

[23]Patent:WO2014/151863,2014,A1.Locationinpatent:Page/Pagecolumn48

[24]Synthesis,2015,vol.47,p.1091-1100

[25]OrganicLetters,2015,vol.17,p.5898-5901

[26]ChemicalandPharmaceuticalBulletin,2016,vol.64,p.602-608

[27]Patent:WO2017/31325,2017,A1.Locationinpatent:Paragraph0668;0679

[28]Patent:WO2017/102091,2017,A1.Locationinpatent:Page/Pagecolumn346

[29]JournaloftheAmericanChemicalSociety,2017,vol.139,p.12153-12156

[30]EuropeanJournalofMedicinalChemistry,2018,vol.157,p.962-977

[31]OrganicLetters,2020,vol.22,p.234-238

[32]Patent:WO2019/213386,2019,A1.Locationinpatent:Paragraph0175

[33]Patent:WO2020/88659,2020,A1.Locationinpatent:Paragraph00232

5239-82-7    6638-79-5    227322-00-1 

[1]Patent:WO2015/112806,2015,A3.Locationinpatent:Paragraph0308

[2]Patent:US2010/16373,2010,A1.Locationinpatent:Page/Pagecolumn7

[3]Patent:US2020/190045,2020,A1.Locationinpatent:Paragraph0666;0667

[4]Patent:WO2017/97732,2017,A1.Locationinpatent:Page/Pagecolumn51;52

[5]Synlett,2019,vol.30,p.454-458

[6]Patent:WO2017/21969,2017,A1.Locationinpatent:Page/Pagecolumn29-30

[7]JournalofOrganicChemistry,2003,vol.68,p.9964-9970

[8]Patent:WO2014/97038,2014,A1.Locationinpatent:Page/Pagecolumn77

[9]Patent:WO2016/90285,2016,A1.Locationinpatent:Paragraph00361

[10]Patent:WO2020/115555,2020,A2.Locationinpatent:Page/Pagecolumn178-179

5239-82-7    34108-21-9 

[1]Patent:US2003/187040,2003,A1

[2]JournalofOrganicChemistry,1994,vol.59,p.4791-4799

42392-68-7    5239-82-7 

[1]Smith;McKenzie[JournalofOrganicChemistry,1950,vol.15,p.74,77]

Literature fold

Title: Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3.

Journal: The Journal of biological chemistry20110325

Related Products of of 5239-82-7
10191-25-0
10191-25-0
10237-77-1
10237-77-1
123-76-2
123-76-2
13885-13-7
13885-13-7
150-96-9
150-96-9
150864-95-2
150864-95-2
Building Blocks More >
37619-25-3
37619-25-3
Methyl 1,3-benzodiazole-4-carboxylate
AA0038P6 | MFCD09910212
52004-97-4
52004-97-4
2-Propenoic acid, 2-methyl-, 3-(trimethoxysilyl)propyl ester, homopolymer
AA01X4DL | MFCD00008593
133803-81-3
133803-81-3
Hydroxy-peg2-t-butyl ester
AA0038VF | MFCD20926380
34183-22-7
34183-22-7
1-{2-[2-hydroxy-3-(propylamino)propoxy]phenyl}-3-phenylpropan-1-one hydrochloride
AA0038YN | MFCD00079243
5616-81-9
5616-81-9
tert-Butyl 2-(methylamino)acetate
AA00392D | MFCD00080936
951127-25-6
951127-25-6
tert-Butyl ((2r,3s)-2-(2,5-difluorophenyl)-5-oxotetrahydro-2h-pyran-3-yl)carbamate
AA00396D | MFCD20926096
80-04-6
80-04-6
4,4'-Isopropylidenedicyclohexanol
AA00399Y | MFCD00019334
770718-92-8
770718-92-8
3-bromo-5-hydroxybenzonitrile
AA0039DP | MFCD16659096
868540-17-4
868540-17-4
(αS)-α-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-L-phenylalaninamide
AA0039HG | MFCD11040997
705260-08-8
705260-08-8
Vorapaxar sulfate
AA0039KH | MFCD16038877
Submit
© 2017 AA BLOCKS, INC. All rights reserved.